SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
902 9 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
552CC Slides and Presentation neptunecorp.comSultan-11/13/2018
551Neptune Announces Second Quarter Results finance.yahoo.comSultan-11/13/2018
550Neptune to Hold Conference Call to Discuss Second Quarter Results for the Three Sultan-10/31/2018
549Speculative but have some basis so FWIW.. Coca-Cola Preps For Marijuana Coffee Sultan-10/24/2018
548Acasti Pharma Announces Closing of C$27.6 Million Underwritten Public Offering oSultan-10/23/2018
547Neptune to Exhibit and Present at 2018 Montreal Cannabis Expo finance.yahoo.comSultan-10/22/2018
546ACST FORM 6-K On October 15, 2018, Acasti Pharma Inc. (the “Corporation”) receiSultan-10/19/2018
545Neptune's world-class facility for the extraction and purification of legal Sultan-10/12/2018
544Acasti Pharma Announces Public Equity Offering finance.yahoo.comSultan-10/3/2018
543Neptune will be participating in their first conference, Cannabis Expo Montreal Sultan-10/1/2018
542Neptune October Presentation neptunecorp.com Slide 20, 23 is one of the reasonSultan-10/1/2018
541In FWIW category, ACST closed at US 1.29 up 30% on a volume of 4.8m .. On TSXV, Sultan19/28/2018
540Sidoti & Company Fall 2018 Conference neptunecorp.comSultan-9/27/2018
539Appointment of Caroline Lavoie, Director of Corporate Affairs Neptune submits Sultan-9/27/2018
538Acasti Pharma stock has 1000% upside, Mackie Research says cantechletter.comSultan-9/25/2018
537ACST September Presentation acastipharma.comSultan-9/24/2018
536Here is why I am holding ACST.. Apparently, per Phase II trial, ACST Capre numbeSultan19/24/2018
535The trial is making progress but for now no one is interested.. Today's new Sultan-9/24/2018
534Why the pop in ACST? Sold 35% of my shares at $1.10/share in the pre-market. ME_K_S-9/24/2018
533Acasti Pharma Appoints Jean-François Boily as Vice President of Finance LASultan-9/24/2018
532Neptune to Present at Sidoti & Company Fall 2018 Conference LAVAL, QC, SepSultan-9/20/2018
531Neptune Confirms its Name Change to Neptune Wellness Solutions Inc. LAVAL, QC, Sultan-9/19/2018
530Acasti Pharma Provides Clinical and Market Update TRILOGY phase 3 studies exceeSultan-9/18/2018
529Neptune Receives Confirmation of Readiness Letter from Health Canada Key milesSultan-9/17/2018
528Neptune up 21% on receiving Confirmation of Readiness letter from Health Canada E_K_S-9/17/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News